This novel, randomized clinical trial will evaluate if vitamin K supplementation impacts pain and function in patients with knee OA who are vitamin K insufficient. There is a growing body of epidemiological, genetic and biochemical evidence that vitamin K plays a role in maintaining joint health. The study will provide initial data in support of … Continued
Dr. Richard F. Loeser is the Joseph P. Archie, Jr. Eminent Professor of Medicine in the Division of Rheumatology, Allergy and Immunology. Dr. Doug Phanstiel – who is in the Department of Cell Biology and Physiology – is the principal investigator, and Dr. Loeser is a co-principal investigator for the National Institute of Arthritis and Musculoskeletal and … Continued
Lara Longobardi, PhD, is an associate professor in the Division of Rheumatology, Allergy and Immunology. The research showed early deletion of Ccr2 in aggrecan-expressing cells reduces the initiation, but not the progression, of post traumatic osteoarthritis and its associated pain. View the article published in Osteoarthritis and Cartilage.
Saira Sheikh, MD, associate professor in the Division of Rheumatology, Allergy, and Immunology, was the UNC Principal Investigator. The study, recently published in the New England Journal of Medicine, explored treating adults with cutaneous lupus using litifilimab. The trial was conducted at UNC’s Clinical & Translational Research Center (CTRC), a resource through North Carolina Translational and … Continued
Ginny and Doug Ware have partnered with Saira Sheikh, MD, to support a new fund that will advance science and improve the lives of individuals with autoimmune diseases. Their generous gift was used to create the Virginia A. and Douglas R. Ware Fund for Excellence in Autoimmune Diseases. “This new Fund will support my vision for a program … Continued
Kelli Allen, PhD, professor of medicine in the division of rheumatology, allergy, and immunology, received a grant for a project titled “Optimizing Osteoarthritis Care Through Clinical & Community Partnerships.” The project addresses a critical need to improve care for patients with OA through an evidence-based, comprehensive and sustainable care model. Learn more.
Saira Sheikh, MD, the Linda Coley Sewell Distinguished Professor of Medicine in the division of rheumatology, and research associate Tessa Englund, PhD, MPH, described the barriers in lupus clinical trial enrollment and how they can be addressed to ensure equitable representation. Read the article published in Rheumatology Advisor.
Edwin H. Kim, MD, MS, associate professor of pediatrics and medicine in the division of rheumatology, allergy and immunology, offered his perspective to Healio regarding tips to optimize oral immunotherapy for peanut allergy. Kim is chief of UNC Pediatric Allergy & Immunology. Read the article.
The below clickable headlines link directly to outside media outlets and feature UNC Department of Medicine faculty, starting Friday, November 4, 2021. What every parent should know about Halloween safety | Four 2 Five – Dr. Emily Sickbert-Bennett (MSN.com) Food Allergy Families Seek Out Hard-to-Find Immunotherapy – Dr. Edwin Kim (WebMD) Pandemic-related drinking causing spike in … Continued
Imagine: You have a patient with a penicillin allergy documented in their chart. Typically, you would prescribe amoxicillin for their infection, but that is not an option because it is a penicillin-class antibiotic. Instead, you prescribe a broader-spectrum antibiotic–not your first choice except for the allergy. But, what if you learned that it is not … Continued
Newly released Action Briefs now make it easier for employers, insurers, healthcare systems, policy makers, and leaders in other organizations to take specific, practical actions to support their constituents with osteoarthritis. The Osteoarthritis Action Alliance (OAAA), partnering with the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation, issued A National Public Health … Continued
Thanks to additional support from the CDC, the Osteoarthritis Action Alliance is actively addressing the devastating impact of osteoarthritis on adults and communities through strategic leveraging of partnerships, collaborations, and the resources of its 140+ member organizations. “This is a crucial time, because osteoarthritis (OA) is a leading cause of disability and work limitations among … Continued